Concepts (103)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Bloom Syndrome | 1 | 2015 | 5 | 0.460 |
Why?
|
| Sister Chromatid Exchange | 1 | 2015 | 14 | 0.460 |
Why?
|
| Chromosomal Instability | 1 | 2015 | 58 | 0.450 |
Why?
|
| RecQ Helicases | 1 | 2015 | 62 | 0.440 |
Why?
|
| Genetic Testing | 4 | 2024 | 1056 | 0.330 |
Why?
|
| Vulnerable Populations | 2 | 2024 | 142 | 0.230 |
Why?
|
| Chromothripsis | 1 | 2025 | 10 | 0.230 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2025 | 89 | 0.220 |
Why?
|
| Chromosomes, Human, Pair 5 | 1 | 2025 | 108 | 0.220 |
Why?
|
| Proto-Oncogene Proteins c-ets | 1 | 2024 | 57 | 0.210 |
Why?
|
| Brain Abscess | 1 | 2024 | 52 | 0.210 |
Why?
|
| Apoptosis Regulatory Proteins | 1 | 2024 | 161 | 0.210 |
Why?
|
| Hemiplegia | 1 | 2023 | 42 | 0.200 |
Why?
|
| Suppressor of Cytokine Signaling Proteins | 1 | 2023 | 25 | 0.200 |
Why?
|
| Retinitis Pigmentosa | 1 | 2024 | 89 | 0.200 |
Why?
|
| Neutropenia | 1 | 2024 | 198 | 0.200 |
Why?
|
| Scimitar Syndrome | 1 | 2023 | 52 | 0.190 |
Why?
|
| Exons | 1 | 2025 | 757 | 0.190 |
Why?
|
| Hearing Loss, Sensorineural | 1 | 2024 | 155 | 0.190 |
Why?
|
| UDPglucose 4-Epimerase | 1 | 2021 | 7 | 0.180 |
Why?
|
| Galactosemias | 1 | 2021 | 14 | 0.180 |
Why?
|
| Haploinsufficiency | 1 | 2023 | 265 | 0.180 |
Why?
|
| Congenital Disorders of Glycosylation | 1 | 2021 | 39 | 0.170 |
Why?
|
| Repressor Proteins | 1 | 2024 | 761 | 0.160 |
Why?
|
| Lewy Body Disease | 1 | 2019 | 18 | 0.150 |
Why?
|
| DNA Copy Number Variations | 1 | 2025 | 1004 | 0.150 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2024 | 899 | 0.150 |
Why?
|
| alpha-Synuclein | 1 | 2019 | 124 | 0.140 |
Why?
|
| DNA Repair | 2 | 2018 | 549 | 0.130 |
Why?
|
| Abnormalities, Multiple | 1 | 2023 | 964 | 0.130 |
Why?
|
| Ultraviolet Rays | 1 | 2018 | 191 | 0.130 |
Why?
|
| DNA-Directed DNA Polymerase | 1 | 2016 | 85 | 0.120 |
Why?
|
| Carcinogenesis | 1 | 2018 | 344 | 0.110 |
Why?
|
| Chromosomes, Human | 1 | 2015 | 121 | 0.110 |
Why?
|
| Monte Carlo Method | 1 | 2015 | 99 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2019 | 2893 | 0.100 |
Why?
|
| Parkinson Disease | 1 | 2019 | 701 | 0.090 |
Why?
|
| Mutation | 4 | 2023 | 5941 | 0.090 |
Why?
|
| Heart Defects, Congenital | 1 | 2023 | 1853 | 0.090 |
Why?
|
| Phosphorylation | 1 | 2015 | 1536 | 0.090 |
Why?
|
| Chromosome Deletion | 2 | 2025 | 642 | 0.090 |
Why?
|
| Skin Neoplasms | 1 | 2018 | 880 | 0.080 |
Why?
|
| Neurons | 1 | 2019 | 1919 | 0.080 |
Why?
|
| DNA-Binding Proteins | 1 | 2016 | 1877 | 0.070 |
Why?
|
| Humans | 12 | 2025 | 126753 | 0.070 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2016 | 968 | 0.070 |
Why?
|
| Brain | 1 | 2019 | 3038 | 0.070 |
Why?
|
| Liver Neoplasms | 1 | 2016 | 1351 | 0.060 |
Why?
|
| Genomics | 2 | 2024 | 1546 | 0.060 |
Why?
|
| MEF2 Transcription Factors | 1 | 2025 | 35 | 0.060 |
Why?
|
| Hemangioma, Cavernous, Central Nervous System | 1 | 2024 | 20 | 0.050 |
Why?
|
| Genes, X-Linked | 1 | 2024 | 60 | 0.050 |
Why?
|
| Incidental Findings | 1 | 2024 | 121 | 0.050 |
Why?
|
| Genetics, Medical | 1 | 2024 | 116 | 0.050 |
Why?
|
| Mouth Mucosa | 1 | 2023 | 46 | 0.050 |
Why?
|
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2023 | 10 | 0.050 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2023 | 61 | 0.050 |
Why?
|
| Medically Underserved Area | 1 | 2024 | 87 | 0.050 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2025 | 748 | 0.050 |
Why?
|
| Biological Variation, Population | 1 | 2023 | 26 | 0.050 |
Why?
|
| Eye Proteins | 1 | 2024 | 229 | 0.050 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2025 | 999 | 0.040 |
Why?
|
| Glycolipids | 1 | 2021 | 33 | 0.040 |
Why?
|
| Proto-Oncogene Proteins | 1 | 2024 | 579 | 0.040 |
Why?
|
| Polysaccharides | 1 | 2021 | 140 | 0.040 |
Why?
|
| Female | 5 | 2025 | 68330 | 0.040 |
Why?
|
| Lewy Bodies | 1 | 2019 | 12 | 0.040 |
Why?
|
| RNA-Binding Proteins | 1 | 2023 | 533 | 0.040 |
Why?
|
| DNA End-Joining Repair | 1 | 2019 | 38 | 0.040 |
Why?
|
| Exome | 1 | 2024 | 1064 | 0.040 |
Why?
|
| Mice | 3 | 2023 | 17596 | 0.040 |
Why?
|
| Infant | 2 | 2024 | 12771 | 0.040 |
Why?
|
| Child, Preschool | 2 | 2025 | 14347 | 0.040 |
Why?
|
| Animals | 4 | 2023 | 33051 | 0.040 |
Why?
|
| DNA Breaks, Double-Stranded | 1 | 2019 | 140 | 0.040 |
Why?
|
| Mice, Hairless | 1 | 2018 | 30 | 0.040 |
Why?
|
| Health Services Accessibility | 1 | 2024 | 658 | 0.030 |
Why?
|
| Male | 4 | 2024 | 62543 | 0.030 |
Why?
|
| Genome, Human | 1 | 2025 | 1279 | 0.030 |
Why?
|
| DNA Repair Enzymes | 1 | 2018 | 39 | 0.030 |
Why?
|
| Genetic Variation | 1 | 2024 | 1508 | 0.030 |
Why?
|
| Aflatoxins | 1 | 2016 | 3 | 0.030 |
Why?
|
| Aflatoxin B1 | 1 | 2016 | 4 | 0.030 |
Why?
|
| Cytidine | 1 | 2016 | 10 | 0.030 |
Why?
|
| Membrane Proteins | 1 | 2024 | 1569 | 0.030 |
Why?
|
| DNA Adducts | 1 | 2016 | 71 | 0.030 |
Why?
|
| Adolescent | 2 | 2024 | 20002 | 0.030 |
Why?
|
| Mutagenesis | 1 | 2016 | 332 | 0.030 |
Why?
|
| Cohort Studies | 1 | 2024 | 4954 | 0.030 |
Why?
|
| Recombinant Proteins | 1 | 2018 | 1293 | 0.030 |
Why?
|
| Cell Survival | 1 | 2016 | 841 | 0.030 |
Why?
|
| Chromosome Aberrations | 1 | 2016 | 570 | 0.030 |
Why?
|
| Middle Aged | 2 | 2024 | 27697 | 0.030 |
Why?
|
| DNA Damage | 1 | 2016 | 498 | 0.030 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2024 | 3262 | 0.030 |
Why?
|
| Child | 2 | 2024 | 25101 | 0.030 |
Why?
|
| Fibroblasts | 1 | 2016 | 819 | 0.020 |
Why?
|
| Adult | 2 | 2024 | 30410 | 0.020 |
Why?
|
| Phenotype | 1 | 2021 | 4304 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2019 | 3709 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2019 | 4504 | 0.020 |
Why?
|
| Young Adult | 1 | 2024 | 9665 | 0.020 |
Why?
|
| Aged | 1 | 2024 | 20344 | 0.010 |
Why?
|